Recent Finacing
Recent Raise
InSitu Biologics develops AnestaGel, a non-opioid, fast-acting, long-lasting local anesthetic formulation for post-operative regional pain management, advancing from preclinical studies toward clinical trials.
Focus Areas
Total Raised
Funding round
See the team members at Insitu Biologics.
